Index
1 Market Overview
1.1 Product Overview and Scope of Cancer Early Detection and Diagnosis
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Cancer Early Detection and Diagnosis by Type
1.3.1 Overview: Global Cancer Early Detection and Diagnosis Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Cancer Early Detection and Diagnosis Consumption Value Market Share by Type in 2022
1.3.3 Colorectal Cancer
1.3.4 Liver Cancer
1.3.5 Lung Cancer
1.3.6 Other
1.4 Global Cancer Early Detection and Diagnosis Market by Application
1.4.1 Overview: Global Cancer Early Detection and Diagnosis Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Medical Center
1.4.4 Other
1.5 Global Cancer Early Detection and Diagnosis Market Size & Forecast
1.6 Global Cancer Early Detection and Diagnosis Market Size and Forecast by Region
1.6.1 Global Cancer Early Detection and Diagnosis Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Cancer Early Detection and Diagnosis Market Size by Region, (2018-2029)
1.6.3 North America Cancer Early Detection and Diagnosis Market Size and Prospect (2018-2029)
1.6.4 Europe Cancer Early Detection and Diagnosis Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Cancer Early Detection and Diagnosis Market Size and Prospect (2018-2029)
1.6.6 South America Cancer Early Detection and Diagnosis Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Cancer Early Detection and Diagnosis Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Exact Sciences
2.1.1 Exact Sciences Details
2.1.2 Exact Sciences Major Business
2.1.3 Exact Sciences Cancer Early Detection and Diagnosis Product and Solutions
2.1.4 Exact Sciences Cancer Early Detection and Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Exact Sciences Recent Developments and Future Plans
2.2 Grail
2.2.1 Grail Details
2.2.2 Grail Major Business
2.2.3 Grail Cancer Early Detection and Diagnosis Product and Solutions
2.2.4 Grail Cancer Early Detection and Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Grail Recent Developments and Future Plans
2.3 Genetron Health
2.3.1 Genetron Health Details
2.3.2 Genetron Health Major Business
2.3.3 Genetron Health Cancer Early Detection and Diagnosis Product and Solutions
2.3.4 Genetron Health Cancer Early Detection and Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Genetron Health Recent Developments and Future Plans
2.4 New Horizon Health
2.4.1 New Horizon Health Details
2.4.2 New Horizon Health Major Business
2.4.3 New Horizon Health Cancer Early Detection and Diagnosis Product and Solutions
2.4.4 New Horizon Health Cancer Early Detection and Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 New Horizon Health Recent Developments and Future Plans
2.5 Burning Rock
2.5.1 Burning Rock Details
2.5.2 Burning Rock Major Business
2.5.3 Burning Rock Cancer Early Detection and Diagnosis Product and Solutions
2.5.4 Burning Rock Cancer Early Detection and Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Burning Rock Recent Developments and Future Plans
2.6 Berry Oncology
2.6.1 Berry Oncology Details
2.6.2 Berry Oncology Major Business
2.6.3 Berry Oncology Cancer Early Detection and Diagnosis Product and Solutions
2.6.4 Berry Oncology Cancer Early Detection and Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Berry Oncology Recent Developments and Future Plans
2.7 Shanghai Kunyuan Biotechnology
2.7.1 Shanghai Kunyuan Biotechnology Details
2.7.2 Shanghai Kunyuan Biotechnology Major Business
2.7.3 Shanghai Kunyuan Biotechnology Cancer Early Detection and Diagnosis Product and Solutions
2.7.4 Shanghai Kunyuan Biotechnology Cancer Early Detection and Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Shanghai Kunyuan Biotechnology Recent Developments and Future Plans
2.8 Oncognostic
2.8.1 Oncognostic Details
2.8.2 Oncognostic Major Business
2.8.3 Oncognostic Cancer Early Detection and Diagnosis Product and Solutions
2.8.4 Oncognostic Cancer Early Detection and Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Oncognostic Recent Developments and Future Plans
2.9 Epigenomics
2.9.1 Epigenomics Details
2.9.2 Epigenomics Major Business
2.9.3 Epigenomics Cancer Early Detection and Diagnosis Product and Solutions
2.9.4 Epigenomics Cancer Early Detection and Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Epigenomics Recent Developments and Future Plans
2.10 Abbott
2.10.1 Abbott Details
2.10.2 Abbott Major Business
2.10.3 Abbott Cancer Early Detection and Diagnosis Product and Solutions
2.10.4 Abbott Cancer Early Detection and Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Abbott Recent Developments and Future Plans
2.11 Qiagen
2.11.1 Qiagen Details
2.11.2 Qiagen Major Business
2.11.3 Qiagen Cancer Early Detection and Diagnosis Product and Solutions
2.11.4 Qiagen Cancer Early Detection and Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Qiagen Recent Developments and Future Plans
2.12 iStat Biomedical
2.12.1 iStat Biomedical Details
2.12.2 iStat Biomedical Major Business
2.12.3 iStat Biomedical Cancer Early Detection and Diagnosis Product and Solutions
2.12.4 iStat Biomedical Cancer Early Detection and Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 iStat Biomedical Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Cancer Early Detection and Diagnosis Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Cancer Early Detection and Diagnosis by Company Revenue
3.2.2 Top 3 Cancer Early Detection and Diagnosis Players Market Share in 2022
3.2.3 Top 6 Cancer Early Detection and Diagnosis Players Market Share in 2022
3.3 Cancer Early Detection and Diagnosis Market: Overall Company Footprint Analysis
3.3.1 Cancer Early Detection and Diagnosis Market: Region Footprint
3.3.2 Cancer Early Detection and Diagnosis Market: Company Product Type Footprint
3.3.3 Cancer Early Detection and Diagnosis Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Cancer Early Detection and Diagnosis Consumption Value and Market Share by Type (2018-2023)
4.2 Global Cancer Early Detection and Diagnosis Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Cancer Early Detection and Diagnosis Consumption Value Market Share by Application (2018-2023)
5.2 Global Cancer Early Detection and Diagnosis Market Forecast by Application (2024-2029)
6 North America
6.1 North America Cancer Early Detection and Diagnosis Consumption Value by Type (2018-2029)
6.2 North America Cancer Early Detection and Diagnosis Consumption Value by Application (2018-2029)
6.3 North America Cancer Early Detection and Diagnosis Market Size by Country
6.3.1 North America Cancer Early Detection and Diagnosis Consumption Value by Country (2018-2029)
6.3.2 United States Cancer Early Detection and Diagnosis Market Size and Forecast (2018-2029)
6.3.3 Canada Cancer Early Detection and Diagnosis Market Size and Forecast (2018-2029)
6.3.4 Mexico Cancer Early Detection and Diagnosis Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Cancer Early Detection and Diagnosis Consumption Value by Type (2018-2029)
7.2 Europe Cancer Early Detection and Diagnosis Consumption Value by Application (2018-2029)
7.3 Europe Cancer Early Detection and Diagnosis Market Size by Country
7.3.1 Europe Cancer Early Detection and Diagnosis Consumption Value by Country (2018-2029)
7.3.2 Germany Cancer Early Detection and Diagnosis Market Size and Forecast (2018-2029)
7.3.3 France Cancer Early Detection and Diagnosis Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Cancer Early Detection and Diagnosis Market Size and Forecast (2018-2029)
7.3.5 Russia Cancer Early Detection and Diagnosis Market Size and Forecast (2018-2029)
7.3.6 Italy Cancer Early Detection and Diagnosis Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Cancer Early Detection and Diagnosis Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Cancer Early Detection and Diagnosis Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Cancer Early Detection and Diagnosis Market Size by Region
8.3.1 Asia-Pacific Cancer Early Detection and Diagnosis Consumption Value by Region (2018-2029)
8.3.2 China Cancer Early Detection and Diagnosis Market Size and Forecast (2018-2029)
8.3.3 Japan Cancer Early Detection and Diagnosis Market Size and Forecast (2018-2029)
8.3.4 South Korea Cancer Early Detection and Diagnosis Market Size and Forecast (2018-2029)
8.3.5 India Cancer Early Detection and Diagnosis Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Cancer Early Detection and Diagnosis Market Size and Forecast (2018-2029)
8.3.7 Australia Cancer Early Detection and Diagnosis Market Size and Forecast (2018-2029)
9 South America
9.1 South America Cancer Early Detection and Diagnosis Consumption Value by Type (2018-2029)
9.2 South America Cancer Early Detection and Diagnosis Consumption Value by Application (2018-2029)
9.3 South America Cancer Early Detection and Diagnosis Market Size by Country
9.3.1 South America Cancer Early Detection and Diagnosis Consumption Value by Country (2018-2029)
9.3.2 Brazil Cancer Early Detection and Diagnosis Market Size and Forecast (2018-2029)
9.3.3 Argentina Cancer Early Detection and Diagnosis Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Cancer Early Detection and Diagnosis Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Cancer Early Detection and Diagnosis Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Cancer Early Detection and Diagnosis Market Size by Country
10.3.1 Middle East & Africa Cancer Early Detection and Diagnosis Consumption Value by Country (2018-2029)
10.3.2 Turkey Cancer Early Detection and Diagnosis Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Cancer Early Detection and Diagnosis Market Size and Forecast (2018-2029)
10.3.4 UAE Cancer Early Detection and Diagnosis Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Cancer Early Detection and Diagnosis Market Drivers
11.2 Cancer Early Detection and Diagnosis Market Restraints
11.3 Cancer Early Detection and Diagnosis Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Cancer Early Detection and Diagnosis Industry Chain
12.2 Cancer Early Detection and Diagnosis Upstream Analysis
12.3 Cancer Early Detection and Diagnosis Midstream Analysis
12.4 Cancer Early Detection and Diagnosis Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer